+

WO1997007759A1 - Wound dressings - Google Patents

Wound dressings Download PDF

Info

Publication number
WO1997007759A1
WO1997007759A1 PCT/GB1996/002125 GB9602125W WO9707759A1 WO 1997007759 A1 WO1997007759 A1 WO 1997007759A1 GB 9602125 W GB9602125 W GB 9602125W WO 9707759 A1 WO9707759 A1 WO 9707759A1
Authority
WO
WIPO (PCT)
Prior art keywords
adhesive
dressing
wound
coverage
region
Prior art date
Application number
PCT/GB1996/002125
Other languages
French (fr)
Inventor
Denis Keith Gilding
Simon Ashley Dixon
Original Assignee
Innovative Technologies Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovative Technologies Limited filed Critical Innovative Technologies Limited
Priority to AU68328/96A priority Critical patent/AU6832896A/en
Priority to JP9510005A priority patent/JPH11511348A/en
Priority to EP96928609A priority patent/EP0847261A1/en
Publication of WO1997007759A1 publication Critical patent/WO1997007759A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • A61F13/0246Adhesive bandages or dressings characterised by the skin-adhering layer
    • A61F13/025Adhesive bandages or dressings characterised by the skin-adhering layer having a special distribution arrangement of the adhesive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • A61F13/0203Adhesive bandages or dressings with fluid retention members
    • A61F13/0226Adhesive bandages or dressings with fluid retention members characterised by the support layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00089Wound bandages
    • A61F2013/00217Wound bandages not adhering to the wound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00089Wound bandages
    • A61F2013/00217Wound bandages not adhering to the wound
    • A61F2013/00229Wound bandages not adhering to the wound with alginate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00655Plasters adhesive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00727Plasters means for wound humidity control
    • A61F2013/00761Plasters means for wound humidity control with permeable adhesive layers
    • A61F2013/0077Plasters means for wound humidity control with permeable adhesive layers arranged in lines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00855Plasters pervious to air or vapours
    • A61F2013/00876Plasters pervious to air or vapours vapour permeability >500 g/mg/24h

Definitions

  • the present invention relates to wound dressings.
  • Wound dressings frequently comprise a wound covering component (e.g. a synthetic polymeric film or membrane) and an adhesive for locating the wound covering component in position on a wound.
  • the wound covering component may be intended to be located in direct contact with the wound or to locate a further dressing component (e.g. a hydrogel or an alginate) in position between itself and the wound.
  • the wound covering element will not only cover the wound itself but at its marginal edges will overlie-, and be adhered to. the intact skin surrounding the wound so as to locate the element in place.
  • Conventional wound covering elements are generally provided with a uniform amount of adhesive (provided as a continuous or discontinuous layer) across the entire face of the covering element. In other words, the amount per unit area of adhesive is constant across the surface ofthe wound covering element.
  • a wound dressing comprising a wound covering element provided with adhesive on a face thereof wherein in a marginal region of said face extending around the periphery of the element the percentage of adhesive coverage is greater than in a central region ofthe face bounded by the marginal region, the percentage coverage in said marginal region is greater than 20% ofthe area of said marginal region and the percentage coverage in said central region being a maximum of 50% o the area of said central region. Therefore in the dressing of the invention there is a marginal edge region of the wound covering element having a greater amount of adhesive coverage than in the central region. This marginal region is used for secure fixing of the wound covering element to intact skin around the wound whereas the lower amount of adhesive coverage in the central area is more beneficial for the area over the wound.
  • the adhesive coverage may be continuous (100% coverage) or discontinuous (so as to give greater than 20% but less than 100% coverage).
  • the adhesive coverage in the marginal region is at least 30%, more preferably 50% to 80%.
  • the marginal region extends inwardly of the peripheral edge of the wound covering element by a distance of 0.5 to 2cm, more preferably 0.75 to 1.25cm.
  • the adhesive is provided as a discontinuous layer so as to provide an overall coverage, in the central region, of less than 50%, more preferably less than 40%. e.g. less than 30%.
  • the coverage in the second region may be less than 20%.
  • the wound covering element may be one which is intended to be located in direct contact with the wound or to locate a further component between itself and the wound.
  • the adhesive in the central region of the element is provided as lines of adhesive defining a number of cells in which there is no adhesive at all.
  • the lines of adhesive define hexagonal cells arranged in a honeycomb pattern. It is not however essential that the individual cells be hexagonal since other configurations are possible, e.g. quadrilateral shaped cells.
  • the adhesive in the central region may be provided as a cross-hatch pattern. A further possibility is for the cells to be square.
  • the advantage of having such a pattern of lines defining cells is that, for those areas where the covering element contacts the wound, cell growth is promoted.
  • the central region of the wound covering element is intended to locate a further dressing component (e.g. a hydrogel or an alginate) in position, then it is preferred that the adhesive in the central region of the element is provided as a plurality of concentric rings, e.g. circles, ovals and the like, (and possibly also part- rings) centred on the mid-point of the central area of the covering element.
  • concentric rings provide for control of exudate flow from the wound.
  • the spacing between the rings decreases in a direction going away from the mid-point ofthe covering element.
  • the wound covering element may be a membrane or, more preferably, a film.
  • the film is preferably a breathable film which is of increased MVTR capability in the presence of liquid water as compared to moisture vapour only.
  • MVTR in the presence of liquid water may be measured by ASTM E96BW whereas MVTR in the presence of moisture vapour alone may be measured by ASTM E96B.
  • the value ofthe breathability in the presence of liquid water is at least twice and preferably at least three times that in the presence of moisture vapour alone. The value may be up to 10 or 20 times that for moisture vapour alone.
  • the film will be of a material which has an MVTR in the presence of moisture vapour alone (ASTM E96B) of 1,000 to 5,000 g m "2 24 hr *1 and an MVTR in the presence of liquid water (ASTM E96BW) in the range 3.000 to 30,000 g '2 24hr "1 .
  • the film will have a thickness of 20-70 microns more preferably 30-50 microns, e.g. about 40 microns.
  • the film may for example be of polyurethane.
  • suitable films are available from Alternative Technologies Limited under designations B53-2, C54-2, D56-2.
  • the adhesive is preferably a pressure sensitive adhesive. Obviously the adhesive will be a medically acceptable adhesive.
  • An example of a suitable adhesive is a pressure sensitive adhesive available from Innovative Technologies under the designation IT PSA HT or PSA LT.
  • Fig 1. illustrates one embodiment of wound dressing in accordance with the invention viewed from the adhesive side thereof;
  • Fig 2. illustrates a second embodiment of wound dressing in accordance with the invention again viewed from the adhesive side thereof.
  • the illustrated dressing 1 comprising a moisture permeable film 2 provided on one face thereof (i.e. the face seen in Fig. 1) with an adhesive laid down in two distinct areas.
  • a first area of adhesive is provided at the marginal edge regions 3 extending around the periphery of the. film 2. In these regions 3, the adhesive is provided at a coverage of greater than 20%, e.g. 50% upwards.
  • the other region of adhesive is that area ofthe film 1 bounded by the marginal edge regions 3 which is intended to come into direct contact with a wound.
  • the adhesive is provided in lines 4 defining hexagonal cells 5 in a honeycomb pattern.
  • the dressing illustrated in Fig. 1 is suitable for treatments in which the central region is in direct contact with the wound since the honeycomb pattern in the central region promotes cell growth.
  • the dressing 20 illustrated therein includes adhesive laid down at a marginal region 21 extending around the periphery of the dressing.
  • the adhesive is provided at a coverage of > 20%, e.g. 50%.
  • the adhesive is provided as concentric circles 22 and part-circles 23 centred on the mid-point of the central region. There is no adhesive coverage between adjacent circles 22 or part circles 23 so that in the central region the overall coverage is less than 20%.
  • the circles and part circles are of decreasing spacing going in the radial direction away from the centre ofthe dressing.
  • the dressing illustrated in Fig. 2 is particularly suitable for location of a further dressing component (e.g. a hydrogel or alginate) between itself and the wound.
  • a further dressing component e.g. a hydrogel or alginate
  • the concentric circles are effective for prevention of exudate leakage.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A wound dressing (1) comprising a wound covering element (2) provided with adhesive on a face thereof. In a marginal region (3) of said face, extending around the periphery of the element, the percentage of adhesive coverage is greater than in a central region of the face bounded by the marginal region (3). The percentage coverage in said marginal region (3) is greater than 20 % of the area of said marginal region and the percentage coverage in said central region is a maximum of 50 % of the area of the central region.

Description

WOUND DRESSINGS
The present invention relates to wound dressings.
Wound dressings frequently comprise a wound covering component (e.g. a synthetic polymeric film or membrane) and an adhesive for locating the wound covering component in position on a wound. The wound covering component may be intended to be located in direct contact with the wound or to locate a further dressing component (e.g. a hydrogel or an alginate) in position between itself and the wound.
The wound covering element will not only cover the wound itself but at its marginal edges will overlie-, and be adhered to. the intact skin surrounding the wound so as to locate the element in place.
Conventional wound covering elements are generally provided with a uniform amount of adhesive (provided as a continuous or discontinuous layer) across the entire face of the covering element. In other words, the amount per unit area of adhesive is constant across the surface ofthe wound covering element.
"We are however of the view that such uniform amounts are not appropriate to the areas ofthe intact skin and the area ofthe covering element overlying the wound. Thus, for example, a uniform amount which is sufficiently high to allow for secure attachment of the wound covering element to intact skin around the wound may not be appropriate for the area of the element covering the wound itself. Similarly an amount of adhesive appropriate for the area of the element covering the wound may not provide the required degree of securement ofthe element to intact skin.
It is an object of the invention to obviate or mitigate the above mentioned disadvantages.
According to the present invention there is provided a wound dressing comprising a wound covering element provided with adhesive on a face thereof wherein in a marginal region of said face extending around the periphery of the element the percentage of adhesive coverage is greater than in a central region ofthe face bounded by the marginal region, the percentage coverage in said marginal region is greater than 20% ofthe area of said marginal region and the percentage coverage in said central region being a maximum of 50% o the area of said central region. Therefore in the dressing of the invention there is a marginal edge region of the wound covering element having a greater amount of adhesive coverage than in the central region. This marginal region is used for secure fixing of the wound covering element to intact skin around the wound whereas the lower amount of adhesive coverage in the central area is more beneficial for the area over the wound.
Within the marginal region, the adhesive coverage may be continuous (100% coverage) or discontinuous (so as to give greater than 20% but less than 100% coverage).
Preferably the adhesive coverage in the marginal region is at least 30%, more preferably 50% to 80%.
Preferably the marginal region extends inwardly of the peripheral edge of the wound covering element by a distance of 0.5 to 2cm, more preferably 0.75 to 1.25cm.
In the central region of the wound covering element the adhesive is provided as a discontinuous layer so as to provide an overall coverage, in the central region, of less than 50%, more preferably less than 40%. e.g. less than 30%. Thus for example the coverage in the second region may be less than 20%.
The wound covering element may be one which is intended to be located in direct contact with the wound or to locate a further component between itself and the wound.
If the wound covering element is to be in direct contact with the wound, then it is preferred that the adhesive in the central region of the element is provided as lines of adhesive defining a number of cells in which there is no adhesive at all. In a preferred embodiment of this arrangement, the lines of adhesive define hexagonal cells arranged in a honeycomb pattern. It is not however essential that the individual cells be hexagonal since other configurations are possible, e.g. quadrilateral shaped cells. Thus it is possible for the adhesive in the central region to be provided as a cross-hatch pattern. A further possibility is for the cells to be square.
The advantage of having such a pattern of lines defining cells is that, for those areas where the covering element contacts the wound, cell growth is promoted. If however the central region of the wound covering element is intended to locate a further dressing component (e.g. a hydrogel or an alginate) in position, then it is preferred that the adhesive in the central region of the element is provided as a plurality of concentric rings, e.g. circles, ovals and the like, (and possibly also part- rings) centred on the mid-point of the central area of the covering element. Such concentric rings provide for control of exudate flow from the wound.
For preference the spacing between the rings (or part rings) decreases in a direction going away from the mid-point ofthe covering element.
The wound covering element may be a membrane or, more preferably, a film.
The film is preferably a breathable film which is of increased MVTR capability in the presence of liquid water as compared to moisture vapour only. MVTR in the presence of liquid water may be measured by ASTM E96BW whereas MVTR in the presence of moisture vapour alone may be measured by ASTM E96B. Preferably the value ofthe breathability in the presence of liquid water is at least twice and preferably at least three times that in the presence of moisture vapour alone. The value may be up to 10 or 20 times that for moisture vapour alone. Typically .the film will be of a material which has an MVTR in the presence of moisture vapour alone (ASTM E96B) of 1,000 to 5,000 g m "2 24 hr*1 and an MVTR in the presence of liquid water (ASTM E96BW) in the range 3.000 to 30,000 g '2 24hr"1. Typically the film will have a thickness of 20-70 microns more preferably 30-50 microns, e.g. about 40 microns.
The film may for example be of polyurethane. Examples of suitable films are available from Innovative Technologies Limited under designations B53-2, C54-2, D56-2.
The adhesive is preferably a pressure sensitive adhesive. Obviously the adhesive will be a medically acceptable adhesive.
An example of a suitable adhesive is a pressure sensitive adhesive available from Innovative Technologies under the designation IT PSA HT or PSA LT.
The invention is further described by way of example only with reference to the accompanying drawings, in which: Fig 1. illustrates one embodiment of wound dressing in accordance with the invention viewed from the adhesive side thereof; and
Fig 2. illustrates a second embodiment of wound dressing in accordance with the invention again viewed from the adhesive side thereof.
Referring to Fig. 1, the illustrated dressing 1 comprising a moisture permeable film 2 provided on one face thereof (i.e. the face seen in Fig. 1) with an adhesive laid down in two distinct areas.
A first area of adhesive is provided at the marginal edge regions 3 extending around the periphery of the. film 2. In these regions 3, the adhesive is provided at a coverage of greater than 20%, e.g. 50% upwards.
The other region of adhesive is that area ofthe film 1 bounded by the marginal edge regions 3 which is intended to come into direct contact with a wound. In this central area, the adhesive is provided in lines 4 defining hexagonal cells 5 in a honeycomb pattern.
The dressing illustrated in Fig. 1 is suitable for treatments in which the central region is in direct contact with the wound since the honeycomb pattern in the central region promotes cell growth.
Referring now to Fig. 2, the dressing 20 illustrated therein includes adhesive laid down at a marginal region 21 extending around the periphery of the dressing. In this marginal region, the adhesive is provided at a coverage of > 20%, e.g. 50%.
In the central region of the dressing, the adhesive is provided as concentric circles 22 and part-circles 23 centred on the mid-point of the central region. There is no adhesive coverage between adjacent circles 22 or part circles 23 so that in the central region the overall coverage is less than 20%.
The circles and part circles are of decreasing spacing going in the radial direction away from the centre ofthe dressing.
The dressing illustrated in Fig. 2 is particularly suitable for location of a further dressing component (e.g. a hydrogel or alginate) between itself and the wound. The concentric circles are effective for prevention of exudate leakage.

Claims

1. A wound dressing comprising a wound covering element provided with adhesive on a face thereof wherein in a marginal region of said face extending around the periphery of the element the percentage of adhesive coverage is greater than in a central region of the face bounded by the marginal region, the percentage coverage in said marginal region is greater than 20% of the area of said marginal region and the percentage coverage in said central region being a maximum of 50% of the area of said central region.
2. A dressing as claimed in claim 1 wherein, in the marginal region, the adhesive coverage is at least 30%.
3. A dressing as claimed in claim 2 wherein, in the marginal region, the adhesive coverage is 50%-80%.
4. A dressing as claimed in any one of claims 1 to 3 wherein the marginal region extends inwardly of the peripheral edge of the wound covering element by a distance of0.5 to 2cm.
5. A dressing as claimed in claim 4 wherein the marginal region extends inwardly of the peripheral edge of the wound covering element by a distance of 0.75 to 1.25 cm.
6. A wound dressing as claimed in any one of claims 1 to 5 wherein in the central region the percentage of adhesive coverage is less than 40%.
7. A wound dressing as claimed in claim 6 wherein in the central region the percentage of adhesive coverage is less than 30%.
8. A wound dressing as claimed in claim 7 wherein in the central region the percentage of adhesive coverage is less than 20%.
9. A dressing as claimed in claim 8 wherein in the central region of the wound covering element the adhesive is provided at an overall coverage of 10%-20%.
10. A dressing as claimed in any one of claims 1 to 9 wherein in the central region of the element the adhesive is provided as lines defining a plurality of cells.
11. A dressing as claimed in claim 10 wherein the cells are hexagonal and arranged in a honeycomb pattern.
12. A dressing as claimed in any one of claims 1 to 9 wherein the adhesive in the central region of the element is provided as a plurality of concentric rings (and possibly also part-rings) centred on the mid point on the central area of the covering element.
13. A dressing as claimed in any one of claims 1 to 12 wherein the wound covering element is a breathable film.
14. A dressing as claimed in any one of claims 1 to 12 wherein the covering element is a membrane.
PCT/GB1996/002125 1995-08-25 1996-08-27 Wound dressings WO1997007759A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU68328/96A AU6832896A (en) 1995-08-25 1996-08-27 Wound dressings
JP9510005A JPH11511348A (en) 1995-08-25 1996-08-27 Wound dressing
EP96928609A EP0847261A1 (en) 1995-08-25 1996-08-27 Wound dressings

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9517486.8A GB9517486D0 (en) 1995-08-25 1995-08-25 Wound dressings
GB9517486.8 1995-08-25

Publications (1)

Publication Number Publication Date
WO1997007759A1 true WO1997007759A1 (en) 1997-03-06

Family

ID=10779791

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1996/002125 WO1997007759A1 (en) 1995-08-25 1996-08-27 Wound dressings

Country Status (5)

Country Link
EP (1) EP0847261A1 (en)
JP (1) JPH11511348A (en)
AU (1) AU6832896A (en)
GB (1) GB9517486D0 (en)
WO (1) WO1997007759A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229877A1 (en) * 1999-09-17 2002-08-14 Avery Dennison Corporation Pattern coated adhesive article
US7619130B2 (en) 2000-07-18 2009-11-17 Coloplast A/S Multi-layer wound dressing formed as a single unit
WO2013172883A1 (en) * 2012-05-17 2013-11-21 Kinesio Ip Llc Therapeutic tape
EP1675536B1 (en) 2003-09-17 2016-01-20 BSN medical GmbH Wound dressing and method for manufacturing the same
EP3818968A1 (en) * 2019-11-05 2021-05-12 3M Innovative Properties Company Adhesive medical article having fluid management properties

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014274943B2 (en) * 2013-06-04 2019-03-07 Gui Global Products, Ltd. Prophylactic dressing and use of same in the prevention of infection

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE557915C (en) * 1932-08-30 Friedrich Keller Wound healing plaster
WO1991001706A1 (en) * 1989-08-03 1991-02-21 Smith & Nephew Plc Adhesive dressings
EP0538917A1 (en) * 1991-07-29 1993-04-28 The Kendall Company Vented wound dressing
WO1993013813A1 (en) * 1992-01-17 1993-07-22 Coloplast A/S A dressing

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE557915C (en) * 1932-08-30 Friedrich Keller Wound healing plaster
WO1991001706A1 (en) * 1989-08-03 1991-02-21 Smith & Nephew Plc Adhesive dressings
EP0538917A1 (en) * 1991-07-29 1993-04-28 The Kendall Company Vented wound dressing
WO1993013813A1 (en) * 1992-01-17 1993-07-22 Coloplast A/S A dressing

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1229877A1 (en) * 1999-09-17 2002-08-14 Avery Dennison Corporation Pattern coated adhesive article
EP1229877A4 (en) * 1999-09-17 2004-10-27 Avery Dennison Corp ARTICLE WITH AN ADHESIVE PATTERN
US6953602B2 (en) 1999-09-17 2005-10-11 Avery Dennison Corporation Pattern coated adhesive article
US7619130B2 (en) 2000-07-18 2009-11-17 Coloplast A/S Multi-layer wound dressing formed as a single unit
EP1303239B2 (en) 2000-07-18 2013-05-01 Coloplast A/S A dressing
EP1675536B1 (en) 2003-09-17 2016-01-20 BSN medical GmbH Wound dressing and method for manufacturing the same
WO2013172883A1 (en) * 2012-05-17 2013-11-21 Kinesio Ip Llc Therapeutic tape
US9205002B2 (en) 2012-05-17 2015-12-08 Kinesio Ip Llc Therapeutic tape
EP3818968A1 (en) * 2019-11-05 2021-05-12 3M Innovative Properties Company Adhesive medical article having fluid management properties
WO2021090113A1 (en) * 2019-11-05 2021-05-14 3M Innovative Properties Company Adhesive medical article having fluid management properties
CN114599321A (en) * 2019-11-05 2022-06-07 3M创新有限公司 Adhesive medical articles with fluid management properties

Also Published As

Publication number Publication date
AU6832896A (en) 1997-03-19
GB9517486D0 (en) 1995-10-25
JPH11511348A (en) 1999-10-05
EP0847261A1 (en) 1998-06-17

Similar Documents

Publication Publication Date Title
US5086764A (en) Absorbent dressing
US5976117A (en) Wound dressing
EP0538917B1 (en) Vented wound dressing
WO2020060674A1 (en) Super-absorbent, low trauma, advanced wound dressing
EP0081990B1 (en) Film dressing with fabric backing
US4699134A (en) Pressure-relieving bandage
CA1322309C (en) Wound dressing system
EP0081988B1 (en) Composite surgical dressings
EP0107915B1 (en) Surgical dressing
CN102209508B (en) Conformable wound dressing
EP0441418A2 (en) Vented wound dressing
US4635624A (en) Wound dressing
JPH0728907B2 (en) Improved obi
GB1488413A (en) Combination absorbent dressing and flexible cooling devic
CA2182716A1 (en) Adhesive material with removable carrier
CA2515031A1 (en) Conformable wound dressing
US6656495B2 (en) Corn, callus and wart removing pads
WO1997007759A1 (en) Wound dressings
EP0503029A4 (en) Wound dressing having a countoured adhesive layer
US20080021358A1 (en) Blister inhibiting cover dressing and method of using same
WO2002092141A1 (en) Improvements in and relating to adhesive dressings
WO2023023247A1 (en) Bandage with adhesive layer having varying perforation shapes and sizes
KR200493354Y1 (en) Dressing band
JPS6220192Y2 (en)
AU2019215582B2 (en) Wound dressing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 510005

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996928609

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996928609

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1996928609

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载